Penwest Pharmaceuticals reported record second quarter revenue but said it plans new staff cuts in order to build profitability. The company is sharpening its axe to attack "non-drug delivery partnership-funded cash expenses...We expect to achieve these expense reductions by the fourth quarter of this year through a further reduction in staff levels as well as an overall reduction in other costs." Penwest release